Affinage

DPYSL4

Dihydropyrimidinase-related protein 4 · UniProt O14531

Length
572 aa
Mass
61.9 kDa
Annotated
2026-06-09
9 papers in source corpus 8 papers cited in narrative 8 extracted findings
Cross-family judge vs UniProt: Affinage preferred faithfulness: 6/6 claims corpus-supported (100%)

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

DPYSL4 (CRMP3) is a multifunctional cytoskeletal regulator that links microtubule dynamics to neuronal morphogenesis and, independently, to mitochondrial energetics and cancer suppression (PMID:30061407, PMID:17785607, PMID:39938451). In its neuronal role, DPYSL4 is required for hippocampal CA1 dendrite arborization, spine formation, and long-term potentiation (PMID:17785607), a dendritogenic activity that depends on its C-terminus and on L-type voltage-gated calcium channel-dependent Ca2+ influx (PMID:23868973). At the molecular level it shapes the microtubule cytoskeleton through two opposing modes: full-length DPYSL4 inhibits tubulin polymerization and neurite outgrowth, whereas calpain cleavage generates an N-terminally truncated form that translocates to the nucleus and associates with vimentin to drive nuclear condensation (PMID:19559021); it also directly binds katanin p60 (KATNA1) via its D region engaging the KATNA1 MIT domain, enhancing microtubule-severing efficiency to promote neurite length and branching (PMID:39938451). In a distinct pathway, DPYSL4 is a p53 transcriptional target whose dihydropyrimidinase-like domain mediates association with mitochondrial supercomplexes, stimulating ATP production and oxygen consumption and suppressing cancer cell invasion and metastasis (PMID:30061407). In a cancer-promoting context it interacts with SEMA4C, which stabilizes DPYSL4 to drive α-tubulin deacetylation and colon cancer cell motility (PMID:35261797). DPYSL4 also regulates dental epithelial proliferation and differentiation during tooth germ morphogenesis (PMID:23630450).

Mechanistic history

Synthesis pass · year-by-year structured walk · 8 steps
  1. 2000 Medium

    Established that CRMP3/DPYSL4 functions within protein complexes in brain, providing the first physical-partner context by linking it to a CRAM family protein and to tyrosine kinase activity.

    Evidence Co-expression and reciprocal co-IP in COS-7 cells plus IP of rat brain extracts coupled to tyrosine kinase activity assay

    PMID:10851247

    Open questions at the time
    • Identity of the associated tyrosine kinase not resolved
    • Functional consequence of the CRAM complex unknown
    • No structural mapping of the interaction
  2. 2007 High

    Defined an in vivo neuronal requirement, showing DPYSL4 is needed for hippocampal dendrite morphogenesis, spine formation, and synaptic plasticity rather than being merely a brain-enriched marker.

    Evidence Targeted gene disruption in mice with Golgi staining, immunohistochemistry, and LTP electrophysiology

    PMID:17785607

    Open questions at the time
    • Molecular pathway connecting DPYSL4 to dendrite growth not defined in this study
    • Mechanism of LTP impairment unresolved
  3. 2009 Medium

    Revealed a dual cytoskeletal mechanism in which full-length DPYSL4 inhibits tubulin polymerization while calpain cleavage redirects it to the nucleus to bind vimentin, connecting proteolytic processing to subcellular relocalization.

    Evidence In vitro tubulin polymerization assays, overexpression of full-length vs. truncated forms, nuclear pulldown/MS, and vimentin-null neuron experiments

    PMID:19559021

    Open questions at the time
    • Trigger and physiological context for calpain cleavage unclear
    • Functional consequence of nuclear vimentin association beyond condensation not defined
    • Single lab
  4. 2013 Medium

    Mapped the dendritogenic activity to the C-terminus and tied DPYSL4-driven dendrite growth to L-type calcium channel-dependent Ca2+ influx, linking morphology to signaling.

    Evidence Deletional domain mapping, siRNA knockdown, L-type channel pharmacology, and Ca2+ imaging in hippocampal neurons

    PMID:23868973

    Open questions at the time
    • How the C-terminus couples to calcium channels mechanistically unknown
    • Direct binding partners mediating Ca2+ effect not identified
  5. 2013 Medium

    Extended DPYSL4 function beyond neurons by showing it controls dental epithelial proliferation, polarization, and differentiation during tooth germ morphogenesis.

    Evidence Knockdown and overexpression in tooth germ with cellular phenotype and ameloblast marker analysis

    PMID:23630450

    Open questions at the time
    • Molecular effectors in epithelium not defined
    • Relationship to its cytoskeletal activities untested
  6. 2018 High

    Identified a non-cytoskeletal role as a p53 target that engages mitochondrial supercomplexes through its dihydropyrimidinase-like domain to boost oxidative phosphorylation and suppress cancer invasion.

    Evidence ChIP-seq, CRISPR/siRNA knockdown, domain-deletion mutagenesis, mitochondrial co-fractionation, ATP/O2 assays, and xenograft/metastasis models

    PMID:30061407

    Open questions at the time
    • Identity of the supercomplex components contacted not resolved
    • Mechanism by which OXPHOS stimulation suppresses invasion unclear
  7. 2022 Medium

    Assigned an α-tubulin deacetylase function stabilized by SEMA4C, defining a cancer-promoting axis that opposes the tumor-suppressive mitochondrial role.

    Evidence Co-IP of SEMA4C–CRMP3, tubulin acetylation Westerns, overexpression/neutralizing antibody, and HDAC inhibitor rescue in colon cancer cells

    PMID:35261797

    Open questions at the time
    • No in vitro deacetylase reconstitution to confirm direct enzymatic activity
    • Reconciliation with tumor-suppressive role in other contexts unaddressed
  8. 2025 High

    Provided a direct biochemical mechanism for DPYSL4 in neurite growth by showing its D region binds the KATNA1 MIT domain to enhance microtubule-severing.

    Evidence GST pulldown, co-IP, domain-mapping mutants, in vitro microtubule-severing assays, and CRISPR knockout in hippocampal neurons

    PMID:39938451

    Open questions at the time
    • How severing enhancement integrates with the tubulin-polymerization-inhibiting activity unresolved
    • Regulation of the DPYSL4–KATNA1 interaction unknown

Open questions

Synthesis pass · forward-looking unresolved questions
  • How DPYSL4's opposing molecular activities—tubulin polymerization inhibition, katanin-enhanced severing, α-tubulin deacetylation, and mitochondrial supercomplex association—are coordinated and switched between contexts remains unresolved.
  • No unifying model linking cytoskeletal and mitochondrial roles
  • Context-dependent tumor-suppressive vs. tumor-promoting behavior unexplained
  • Upstream regulation of calpain processing and SEMA4C stabilization unmapped

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0008092 cytoskeletal protein binding 2 GO:0098772 molecular function regulator activity 1 GO:0140096 catalytic activity, acting on a protein 1
Localization
GO:0005856 cytoskeleton 2 GO:0005634 nucleus 1 GO:0005739 mitochondrion 1
Pathway
R-HSA-112316 Neuronal System 2 R-HSA-1643685 Disease 2 R-HSA-1430728 Metabolism 1
Complex memberships
mitochondrial respiratory supercomplexes

Evidence

Reading pass · 8 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2018 DPYSL4 is a p53 transcriptional target that associates with mitochondrial supercomplexes via its dihydropyrimidinase-like domain; overexpression upregulates ATP production and oxygen consumption, while deletion of the dihydropyrimidinase-like domain abolishes both mitochondrial supercomplex association and the ability to stimulate ATP production and suppress cancer cell invasion. ChIP-seq (p53 binding), siRNA/CRISPR-Cas9 knockdown, domain-deletion mutant overexpression, ATP/oxygen consumption assays, co-fractionation with mitochondrial supercomplexes, mouse xenograft and lung-metastasis models Proceedings of the National Academy of Sciences of the United States of America High 30061407
2000 CRMP3 (DPYSL4) physically associates with CRAM (a novel unc-33 family protein) when co-expressed in COS-7 cells and forms a large complex in rat brain; brain extracts show co-immunoprecipitation of CRMP3 with proteins bearing protein-tyrosine kinase activity. Co-expression in COS-7 cells with co-immunoprecipitation; immunoprecipitation of rat brain extracts followed by protein-tyrosine kinase activity assay The Journal of biological chemistry Medium 10851247
2007 CRMP3 (DPYSL4) is required for normal hippocampal CA1 apical and basal dendrite morphogenesis and spine formation in vivo; CRMP3-knockout mice display abnormal dendrite undulation, reduced length, altered branching, and impaired long-term potentiation. Targeted gene disruption in mice; immunohistochemistry; Golgi staining of dendrite morphology; electrophysiological LTP measurement FASEB journal High 17785607
2009 Full-length CRMP3 inhibits tubulin polymerization and neurite outgrowth in mature cerebellar granule neurons; calpain-cleaved N-terminal truncated CRMP3 undergoes nuclear translocation through nuclear pores and associates with nuclear vimentin, causing nuclear condensation. Overexpression of full-length vs. truncated CRMP3 in cultured cerebellar granule neurons; in vitro tubulin polymerization assay; nuclear protein pull-down with mass spectrometry; co-localization immunofluorescence; vimentin-null neuron experiments Experimental cell research Medium 19559021
2013 The C-terminus of CRMP3 is necessary for its dendritogenic capacity and supports active transport in hippocampal neurons; C-terminally truncated CRMP3 phenocopies CRMP3 gene deletion and acts as a dominant-negative inhibitor. CRMP3-mediated dendritic growth requires L-type voltage-gated calcium channel activity, as L-type channel inhibitors block CRMP3-induced dendritic growth and augmented somatic Ca2+ influx. Deletional domain mapping by overexpression in hippocampal neurons; siRNA knockdown; voltage-gated calcium channel pharmacological inhibition; Ca2+ imaging Journal of cell science Medium 23868973
2022 CRMP3 interacts with semaphorin 4C (SEMA4C) and functions as a deacetylase for α-tubulin; SEMA4C stabilizes CRMP3 to increase α-tubulin deacetylation and promote colon cancer cell motility, an effect attenuated by HDAC inhibitors. Co-immunoprecipitation (SEMA4C–CRMP3 interaction); Western blotting for tubulin acetylation; ectopic overexpression and neutralizing antibody treatment; HDAC inhibitor treatment American journal of cancer research Medium 35261797
2013 Dpysl4 (CRMP3/DPYSL4) regulates dental epithelial cell proliferation, polarization, and differentiation during tooth germ morphogenesis; knockdown promotes proliferation and inhibits differentiation of inner enamel epithelial cells into pre-ameloblasts, while overexpression inhibits growth and increases Msx2 expression. Knockdown and overexpression of Dpysl4 in tooth germ; analysis of cell polarization, columnar structure formation, and ameloblast marker gene expression International journal of biological sciences Medium 23630450
2025 CRMP3 directly binds KATNA1 (katanin p60) via CRMP3's D region (residues 64–413) and KATNA1's MIT domain (residues 1–77); this interaction enhances KATNA1's microtubule-severing efficiency and promotes hippocampal neurite length and branching, with genetic knockout of either or both proteins inhibiting neurite outgrowth. GST pulldown, co-immunoprecipitation, domain-mapping mutants, microtubule-severing assays, overexpression and CRISPR knockout in cultured hippocampal neurons Biochemical and biophysical research communications High 39938451

Source papers

Stage 0 corpus · 9 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2000 Identification of CRAM, a novel unc-33 gene family protein that associates with CRMP3 and protein-tyrosine kinase(s) in the developing rat brain. The Journal of biological chemistry 84 10851247
2007 CRMP3 is required for hippocampal CA1 dendritic organization and plasticity. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 66 17785607
2018 p53-inducible DPYSL4 associates with mitochondrial supercomplexes and regulates energy metabolism in adipocytes and cancer cells. Proceedings of the National Academy of Sciences of the United States of America 51 30061407
2007 Antibodies to CRMP3-4 associated with limbic encephalitis and thymoma. Clinical and experimental immunology 30 17403058
2009 Characterization of the role of full-length CRMP3 and its calpain-cleaved product in inhibiting microtubule polymerization and neurite outgrowth. Experimental cell research 25 19559021
2013 Mapping CRMP3 domains involved in dendrite morphogenesis and voltage-gated calcium channel regulation. Journal of cell science 22 23868973
2022 Semaphorin 4C promotes motility and immunosuppressive activity of cancer cells via CRMP3 and PD-L1. American journal of cancer research 7 35261797
2013 Dpysl4 is involved in tooth germ morphogenesis through growth regulation, polarization and differentiation of dental epithelial cells. International journal of biological sciences 7 23630450
2025 The interaction between KATNA1 and CRMP3 modulates microtubule dynamics and neurite outgrowth. Biochemical and biophysical research communications 3 39938451

Missed literature

Know a paper Affinage missed for DPYSL4? Flag it for the maintainers and the community.

No submissions yet.